Sirtuin 1 regulates skeletal myoblast survival and enhances differentiation in the presence of resveratrol

Experimental Physiology

Volumn 97, Issue 3, 2012, Pages 400-418

  Saini, Amarjit ^a,b   Al Shanti, Nasser ^a   Sharples, Adam P ^a,b   Stewart, Claire E ^a  

^a MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF BEDFORDSHIRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RESVERATROL; SIRTUIN 1; SMALL INTERFERING RNA; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; MOUSE; MYOBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STRESS;

EID: 84857651839     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2011.061028     Document Type: Article

References (48)

1. Anderson RM, Bitterman KJ, Wood JG, Medvedik O & Sinclair DA (2003). Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae. Nature 423, 181-185.
2. Bartke A, Chandrashekar V, Dominici F, Turyn D, Kinney B, Steger R & Kopchick JJ (2003). Insulin-like growth factor 1 (IGF-1) and aging: controversies and new insights. Biogerontology 4, 1-8.
3. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R & Sinclair DA (2006). Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337-342.
4. Blander G & Guarente L (2004). The Sir2 family of protein deacetylases. Annu Rev Biochem 73, 417-435.
5. Blau HM, Pavlath GK, Hardeman EC, Chiu CP, Silberstein L, Webster SG, Miller SC & Webster C (1985). Plasticity of the differentiated state. Science 230, 758-766.
6. Bonafè M, Barbieri M, Marchegiani F, Olivieri F, Ragno E, Giampieri C, Mugianesi E, Centurelli M, Franceschi C & Paolisso G (2003). Polymorphic variants of insulin-like growth factor I (IGF-I) receptor and phosphoinositide 3-kinase genes affect IGF-I plasma levels and human longevity: cues for an evolutionarily conserved mechanism of life span control. J Clin Endocrinol Metab 88, 3299-3304.
7. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, Hu LS, Cheng HL, Jedrychowski MP, Gygi SP, Sinclair DA, Alt FW & Greenberg ME (2004). Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303, 2011-2015.
8. Bruunsgaard H, Andersen-Ranberg K, Hjelmborg JB, Pedersen BK & Jeune B (2003a). Elevated levels of tumor necrosis factor alpha and mortality in centenarians. Am J Med 115, 278-283.
9. Bruunsgaard H, Ladelund S, Pedersen AN, Schroll M, Jørgensen T & Pedersen BK (2003b). Predicting death from tumour necrosis factor-alpha and interleukin-6 in 80-year-old people. Clin Exp Immunol 132, 24-31.
10. Clancy DJ, Gems D, Harshman LG, Oldham S, Stocker H, Hafen E, Leevers SJ & Partridge L (2001). Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 292, 104-106.
11. Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, Kessler B, Howitz KT, Gorospe M, de Cabo R & Sinclair DA (2004). Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305, 390-392.
12. Crown AL, He XL, Holly JM, Lightman SL & Stewart CE (2000). Characterisation of the IGF system in a primary adult human skeletal muscle cell model, and comparison of the effects of insulin and IGF-I on protein metabolism. J Endocrinol 167, 403-415.
13. Degens H & Alway SE (2003). Skeletal muscle function and hypertrophy are diminished in old age. Muscle Nerve 27, 339-347.
14. Denu JM (2005). The Sir 2 family of protein deacetylases. Curr Opin Chem Biol 9, 431-440.
15. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K & Tuschl T (2001a). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498.
16. Elbashir SM, Lendeckel W & Tuschl T (2001b). RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 15, 188-200.
17. Elbashir SM, Martinez J, Patkaniowska A, Lendeckel W & Tuschl T (2001c). Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J 20, 6877-6888.
18. Florini JR, Magri KA, Ewton DZ, James PL, Grindstaff K & Rotwein PS (1991). "Spontaneous" differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II. J Biol Chem 266, 15917-15923.
19. Foulstone EJ, Huser C, Crown AL, Holly JM & Stewart CE (2004). Differential signalling mechanisms predisposing primary human skeletal muscle cells to altered proliferation and differentiation: roles of IGF-I and TNFα. Exp Cell Res 294, 223-235.
20. Fulco M, Cen Y, Zhao P, Hoffman EP, McBurney MW, Sauve AA & Sartorelli V (2008). Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev Cell 14, 661-673.
21. Fulco M, Schiltz RL, Iezzi S, King MT, Zhao P, Kashiwaya Y, Hoffman E, Veech RL & Sartorelli V (2003). Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state. Mol Cell 12, 51-62.
22. Gems D & Partridge L (2001). Insulin/IGF signalling and ageing: seeing the bigger picture. Curr Opin Genet Dev 11, 287-292.
23. Guarente L & Picard F (2005). Calorie restriction-the SIR2 connection. Cell 120, 473-482.
24. Higami Y & Shimokawa I (2000). Apoptosis in the aging process. Cell Tissue Res 301, 125-132.
25. Imai S, Armstrong CM, Kaeberlein M & Guarente L (2000). Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403, 795-800.
26. Kaeberlein M, McDonagh T, Heltweg B, Hixon J, Westman EA, Caldwell SD, Napper A, Curtis R, DiStefano PS, Fields S, Bedalov A & Kennedy BK (2005). Substrate-specific activation of sirtuins by resveratrol. J Biol Chem 280, 17038-17045.
27. Kaeberlein M, McVey M & Guarente L (1999). The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev 13, 2570-2580.
28. Langley E, Pearson M, Faretta M, Bauer UM, Frye RA, Minucci S, Pelicci PG & Kouzarides T (2002). Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J 21, 2383-2396.
29. Lees SJ, Zwetsloot KA & Booth FW (2009). Muscle precursor cells isolated from aged rats exhibit an increased tumor necrosis factor-α response. Aging Cell 8, 26-35.
30. Leong CW, Wong CH, Lao SC, Leong EC, Lao IF, Law PT, Fung KP, Tsang KS, Waye MM, Tsui SK, Wang YT & Lee SM (2007). Effect of resveratrol on proliferation and differentiation of embryonic cardiomyoblasts. Biochem Biophys Res Commun 360, 173-180.
31. Longo VD & Kennedy BK (2006). Sirtuins in aging and age-related disease. Cell 126, 257-268.
32. Markus MA & Morris BJ (2008). Resveratrol in prevention and treatment of common clinical conditions of aging. Clin Interv Aging 3, 331-339.
33. Masoro EJ (2000). Caloric restriction and aging: an update. Exp Gerontol 35, 299-305.
34. Morse CI, Thom JM, Mian OS, Muirhead A, Birch KM & Narici MV (2005). Muscle strength, volume and activation following 12-month resistance training in 70-year-old males. Eur J Appl Physiol 95, 197-204.
35. Motta MC, Divecha N, Lemieux M, Kamel C, Chen D, Gu W, Bultsma Y, McBurney M & Guarente L (2004). Mammalian SIRT1 represses forkhead transcription factors. Cell 116, 551-563.
36. Rathbone CR, Booth FW & Lees SJ (2009). Sirt1 increases skeletal muscle precursor cell proliferation. Eur J Cell Biol 88, 35-44.
37. Saini A, Al-Shanti N, Faulkner SH & Stewart CE (2008). Pro- and anti-apoptotic roles for IGF-I in TNF-α-induced apoptosis: a MAP kinase mediated mechanism. Growth Factors 26, 239-253.
38. Saini A, Faulkner S, Al-Shanti N & Stewart C (2009). Powerful signals for weak muscles. Ageing Res Rev 8, 251-267.
39. +-dependent deacetylation reactions. Biochemistry 40, 15456-15463.
40. Sharples AP, Al-Shanti N & Stewart CE (2010). C2 and C2C12 murine skeletal myoblast models of atrophic and hypertrophic potential: relevance to disease and ageing? J Cell Physiol 225, 240-250.
41. Solomon JM, Pasupuleti R, Xu L, McDonagh T, Curtis R, DiStefano PS & Huber LJ (2006). Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage. Mol Cell Biol 26, 28-38.
42. Stewart CE, Newcomb PV & Holly JM (2004). Multifaceted roles of TNF-α in myoblast destruction: a multitude of signal transduction pathways. J Cell Physiol 198, 237-247.
43. Stewart CE, Newcomb PV, Savage PB, Dickens M, Tavare J & Holly JM (1999). Increased, not decreased activation of the insulin-like growth factor (IGF) receptor signalling pathway during ceramide-induced apoptosis. Growth Horm IGF Res 9, 131-142.
44. Tang BL (2006). SIRT1, neuronal cell survival and the insulin/IGF-1 aging paradox. Neurobiol Aging 27, 501-505.
45. Tang TT, Dowbenko D, Jackson A, Toney L, Lewin DA, Dent AL & Lasky LA (2002). The forkhead transcription factor AFX activates apoptosis by induction of the BCL-6 transcriptional repressor. J Biol Chem 277, 14255-14265.
46. Tatar M, Bartke A & Antebi A (2003). The endocrine regulation of aging by insulin-like signals. Science 299, 1346-1351.
47. Tuschl T (2001). RNA interference and small interfering RNAs. Chembiochem 2, 239-245.
48. Yaffe D & Saxel O (1977). Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270, 725-727.